Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sandler

Showing results (661-670 of 870) with videos related to

Pageof 87
Sort By:
Cancer|November 21, 2014
Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413Daniel A Hamstra, Kyounghwa Bae, Gerald Hanks, et al.
Psychopharmacology|April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'J D Elsworth, V Glover, G P Reynolds, et al.
Medical Care|April 21, 2007
Treatment choice and quality of care for men with localized prostate cancerDavid C Miller, Benjamin A Spencer, Jamie Ritchey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapyDavid C Miller, Martin G Sanda, Rodney L Dunn, et al.
International Journal of Radiation Oncology, Biology, Physics|November 19, 2008
Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohortsCécile Proust-Lima, Jeremy M G Taylor, Scott G Williams, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406Jeff Michalski, Kathryn Winter, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1997
Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumorsM K Martel, H M Sandler, W T Cornblath, et al.
BJU International|May 3, 2017
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancerZachary S Zumsteg, Michael J Zelefsky, Kaitlin M Woo, et al.
Urology|July 13, 2004
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategyJoseph M Herman, David C Smith, James Montie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminomaJune L Chan, Mohammed U Kabeto, A Elizabeth Oldread, et al.
Pageof 87

Showing results (661-670 of 870) with videos related to

Sort By:
Pageof 87
Cancer|November 21, 2014
Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413Daniel A Hamstra, Kyounghwa Bae, Gerald Hanks, et al.
Psychopharmacology|April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'J D Elsworth, V Glover, G P Reynolds, et al.
Medical Care|April 21, 2007
Treatment choice and quality of care for men with localized prostate cancerDavid C Miller, Benjamin A Spencer, Jamie Ritchey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapyDavid C Miller, Martin G Sanda, Rodney L Dunn, et al.
International Journal of Radiation Oncology, Biology, Physics|November 19, 2008
Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohortsCécile Proust-Lima, Jeremy M G Taylor, Scott G Williams, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406Jeff Michalski, Kathryn Winter, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1997
Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumorsM K Martel, H M Sandler, W T Cornblath, et al.
BJU International|May 3, 2017
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancerZachary S Zumsteg, Michael J Zelefsky, Kaitlin M Woo, et al.
Urology|July 13, 2004
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategyJoseph M Herman, David C Smith, James Montie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminomaJune L Chan, Mohammed U Kabeto, A Elizabeth Oldread, et al.
Pageof 87